• Thursday, Jul 02, 2020
  • Last Update : 12:10 pm

Fujifilm: Covid-19 drug research may drag on into July

  • Published at 02:42 pm June 7th, 2020
Avigan tablets-Japan-Covid-19-coronavirus
File photo: Anti-influenza Avigan tablets produced by Japan's Fujifilm are displayed in Tokyo on October 22, 2014 AFP

After the government of Prime Minister Shinzo Abe gave up on getting approval for the drug by the end of May, the aim was to complete clinical trials this month

Fujifilm Holdings Corp's research on Avigan as a potential treatment for Covid-19 may drag on until July, the company said on Sunday, a further setback in the Japanese firm's race to find a vaccine.

"There is a possibility that clinical trials will continue in July," a Fujifilm spokesman said, responding to a Nikkei report that any approval will be delayed until July or later, due to a lack of patients for trials.

After the government of Prime Minister Shinzo Abe gave up on getting approval for the drug by the end of May, the aim was to complete clinical trials this month.

But researchers have only been able to get around 70% of the patients needed for the trials, and because it takes 28 days to get results, the process will continue until at least July, the Nikkei business daily said, citing an unnamed source.

The spokesman said Fujifilm does not make public details of the progress of clinical trials but it has expanded the number of medical institutions that are cooperate in the trials. "We aim to complete clinical trials as soon as possible."

Drug makers around the world are scrambling to develop a vaccine for the new coronavirus, which has infected over 7 million people globally, while the disease it causes, Covid-19, has killed nearly 400,000.

Many countries are focusing on drugs like Gilead Sciences Inc's antiviral remdesivir and some are using the anti-malaria drug hydroxychloroquine, touted by US President Donald Trump. Abe's government has championed Japanese candidate Avigan, also known as Favipiravir.

Countries that have succeeded in curbing infections have sometimes paradoxically found it difficult to sustain clinical trials because of dwindling sample sizes for patients.

Japan has avoided the explosive outbreaks seen in some other nations, with about 17,000 infections, and the number of daily infections has been falling, according to public broadcaster NHK and the health ministry.

56
55
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail